Glycogen storage disease (GSD) Ib is a metabolic disorder characterized by a deficiency of glucose 6phosphate transporter and neutrophil alterations, which are reduced in number and functionally impaired. The present study aimed at investigating neutrophil dysfunction correlating submembrane and cytoskeletal changes at different ages with or without granulocyte-colony stimulating factor (G-CSF) treatment. GSDlb neutrophils showed reduced expression and diffused localization of focal adhesion kinase (FAK) and actin. No abnormalities were observed in GSDla patient neutrophils. Gelsolin was also slightly reduced in neutrophils of GSD1b patients. When patients were treated for at least 3 months with G-CSF, the neutrophil number and the expression of FAK and actin were significantly increased. Granulocyte colony-stimulating factor treatment was similarly effective when performed in 1 year old patients. FAK auto-and IL-8-mediated phosphorylations were already affected as early as 1 year of age. G-CSF treatment also improved this alteration. Our data suggest that neutrophil dysfunction in GSDlb patients might be related to functional impairment and disorganization of proteins of the sub-membrane apparatus, and that G-CSF treatment counteracts neutropenia and prevents the progressive alterations of neutrophil sub-membrane proteins.
Glycogen storage disease (GSD) type I is an autosomal recessive disorder characterized by defective activity of glucose-6-phosphatase, which catalyzes the terminal steps in gluconeogenesis and glycogenolysis by converting glucose-6phosphate to glucose and phosphate (l). These patients are unable to accurately maintain glucose homeostasis and metabolism. Clinical manifestations are growth retardation, hepatomegaly, hypoglycemia, lactic acidemia, hyperuricemia, hyperlipidemia and hyperfiltration (2) (3) (4) . The subtype GSD la is the most prevalent form, and is caused by mutations in the glucose-6phosphatase gene that greatly impair enzymatic activity, while the GSD Ib form is much rarer and characterized by a defective microsomal glucose-6-phosphate transporter (5) (6) . In addition to the metabolic derangement, GSD Ib patients are affected by infectious complications secondary to quantitative and functional neutrophil deficiencies (7 -8) . Whereas, neutropenia is transient and evident only during the first 4 weeks oflife in mice lacking the glucose-6-phosphate transporter (G6PT) (9) . In GSD Ib patients, neutrophils show defective intracellular bacterial killing associated to reduced chemotaxis, mobility, and migration with insufficient superoxide generation, diminished respiratory burst activity and altered phagocytosis partly due to insufficient calcium mobilization and diminished calcium intracellular stores (10) (11) (12) . Infections most commonly involve skin, perirectal area, ears, urinary tract and bowel. More severe and life-threatening infections cause sepsis, pneumonia, and meningitis. Treatment of GSD 1b patients consists of a combination of dietary therapy, to compensate the metabolic deficiency, and supplementation of human G-CSF to restore neutrophil/monocyte number and function (13) (14) (15) . G-CSF is a haematopoietic growth factor capable of stimulating proliferation and differentiation of granulocyte haematopoietic progenitors, increasing survival, phagocytic and bactericidal activity of mature neutrophils (16) (17) . Administration of G-CSF to GSD 1b patients promotes the increase of the number of neutrophil, and the reduction in severity and frequency of infections (18) .
In acute inflammation neutrophils are primary effector cells, that are rapidly recruited from the bloodstream to local inflammatory sites by a sequence of events starting with the adhesion to vascular endothelium, followed by transendothelial migration, and chemotaxis. Focal adhesion kinase (FAK) is a cytosolic kinase present at high levels in focal adhesion sites originated by clustering of integrins. Such complexes are also associated with a number of intracellular proteins, which include u-actinin, talin, tensin, paxillin, and vinculin (19) . The interaction of integrins with appropriate ligands enhances FAK tyrosine phosphorylation and leads to the organization of focal adhesion sites with anchoring of actin-myosin microfilaments bundled in stress fibers (20) (21) . Another important cellular regulator of cytoskeletal organization, responsive to chemotactic agonists, is gelsolin, a Ca 2 +-and polyphosphoinositide-regulated actin-binding protein, that regulates the extent of neutrophil actin polymerization, an essential response for cell motility (22) (23) . Gelsolin binds, and, subsequently, severes actin filaments. Gelsolin then remains attached to the barbed end of the filament as a cap of the disassembled actin network (24) .
In this study we have evaluated the association of submembrane proteins with neutrophil dysfunction and response to G-CSF in GSD 1b. Our observations were compared to those obtained from apparently normal GSD 1a patient neutrophils.
MATERIALS AND METHODS

Patients
The study had a total duration of 4 years. Patients with a confirmed diagnosis of GSD Ib and Ia were eligible for enrollment in the study. Diagnosis was performed on frozen and fresh hepatic biopsies by assaying the activity of glucose-o-phosphatase, and neutrophil dysfunction was defined by an in vitro assay; both assays were performed by the laboratory of clinical chemistry of San Paolo Hospital. A total of 22 subjects were enrolled in the study: II were affected by GSD 1b, 5 by GSD 1a and 6 were controls. At study entry, the age of GSD 1b patients ranged from I to 27 years. G-CSFtreatment (Neupogen; Amgen, Munich, Germany) was administrated to three young patients (between 5 and 20 years old) for three months daily at the dose of 5mg/kg. One 1 year old patient was treated with G-CSF for 2 and a half years.
Peripheral blood samples were obtained from GSD 1b, GSD 1a and healthy donors after informed consent. Approval was obtained from the Institutional Review Board. Informed consent was provided according to the Declaration of Helsinki.
Neutrophils were isolated using Polymorphprep gradient centrifugation according to the manufacturer's instructions (AXIS-SHIELD PoC AS; Oslo, Norway). Blood was layered on Polymorphprep and gradient and centrifuged at 1600 rpm for 30 min. The layer with neutrophils was carefully aspirated and washed twice in balanced salt solution by centrifugation at 1300 rpm for 10 min. This method yielded >95% neutrophils.
Western blotting
Cel1swere lysed and whole-cel1 extracts (50mg) were boiled, and run on a 10% SDS-PAGE gel by electrophoresis. After transfer to nitrocellulose membrane (Amersham; Arlington Height, IL, USA) and blocking at room temperature for 3 h with 5% dry milk (Merck; Darmstadt, Germany), the membranes were incubated overnight at 4°C with antibodies against actin (1: I00; Santa Cruz; Santa Cruz, CA, USA), FAK-COOH terminal (1: 100; Santa Cruz) and gelsolin (1: 100; Santa Cruz). The membranes were washed, incubated for 1 hour with horseradish peroxidase(HRP)-conjugated anti-goat antibody for actin and gelsolin or anti-rabbit antibody for FAK (1:10000; Chemicon; Temecula, CA, USA). The reaction was revealed using the ECL detection method (ECL kit, Amersham Pharmacia Biotech). patients did not show neutropenia and neutrophil dysfunction, and leukocyte and neutrophil counts were always in the normal range. Controls were healthy subjects of equivalent age range.
FAK is a non-receptor cytosolic kinase that is concentrated in focal contacts and, likely involved in regulation of cell morphology and migration mediated by contact with extracellular matrix proteins (25) (26) . FAK was examined to verify its involvement in the reduced ability of neutrophils from GSD Ib patients to correctly migrate to the inflammatory site. In GSD Ib neutrophils, FAK 
Immunoprecipitation and determination ofauto-and IL-8-mediated FAK activity
Neutrophillysates were incubated for 5 min at 37°C with 400 ng/ml of IL-8 and soon transferred on ice, incubated overnight at 4°C with anti-FAK antibody (0,5 mg/ml of extraction buffer). Protein G-coated Sepharose 4B Fast Flow beads (Sigma; St. Louis, Missouri, USA), were added to the samples and incubated for 3 hours at 4°C, centrifuged, and washed twice in high salt buffer and once in low salt buffer. The immunoprecipitated samples were resuspended in Laemmli buffer, loaded in 10% SDS-PAGE gel and transferred to nitrocellulose. Western blotting was performed as described before and pTyr (BD Transduction Laboratories; Stockholm, Sweden, I: I0000) was used as primary antibody.
Throughout the study we monitored the total leukocyte number and neutrophil percentage of each patient and the range of variability is reported in Table I . Almost all the patients (except for G) had a severe reduction in leukocyte number throughout the observational period. Values of lactic acidemia were suggestive of an adequate dietary compliance by the patients. The standard laboratory tests showed that neutrophils of all GSD Ib patients were defective in chemotaxis, intracellular bacterial killing and altered phagocytosis. In contrast, as expected, GSD Ia Immunofluorescence microscopy Cells were placed on glass slides, permeabilized with 70% methanol for 10 min, dried in air. Primary antibodies for FAK (1 :30), for paxillin (1:30; Santa Cruz) and for vinculin (1:30; Santa Cruz) were applied overnight at 4°C. Samples were incubated for 3 hours at room temperature in blocking buffer containing rhodamine-conjugated goat antibody anti-rabbit for FAK (Chemicon), fluorescin isothiocyanate (FITC)-conjugated donkey antibody antigoat for paxillin and vinculin. F-actin was stained with a fluorescent phalloidin conjugate (Molecular Probes; Eugene, OR, USA) at a final concentration of 5 U/m!. After washing, slides were mounted in 50% glycerol with I mg/ml DAPI. The preparations were examined by confocal microscopy.
Statistical analysis Densitometric analysis was performed by NIH IMAGE 1.44 program by Wayne Rasband (avalaible from Internet by anonymous ftp from zipping, nih, gOY). Data were expressed as optical density. Statistical comparisons were performed by the non parametric Mann-Whitney or Wilcoxon test.
RESULTS
ability ofFAK to autophosphorylate was reduced in GSD 1b patients, thus the decreased expression of FAK was accompanied by impaired autophosphorylation. Exposure of neutrophils to IL-8 promotes phosphorylation of six potential tyrosine phosphorylation sites located on FAK (27) . The incubation with 400ng/ml of IL-8, increased markedly FAK phosphorylation in neutrophils from normal subjects, while the process was only slightly expression was markedly reduced compared to controls ( Fig.1A and 1B) , while it was unaffected in GSOla ( Fig. 1C and 10) .
It is known that FAK-mediated adhesive interactions regulate the assembly of actin-based cytoskeleton; in GSO Ib, actin levels were also significantly lower than controls of equivalent age ( Fig. 2A and 2B ) and GSO 1a patients ( Fig. 2C and  20 ). To determine whether FAK reduction corresponded to changes in activity, we analyzed phosphorylation of FAK after immunoprecipitation from neutrophil preparations of GSD 1b patients and normal subjects. In figure 3 , it is shown that the c o stimulated in neutrophils of both young and adult GSD Ib patients (Fig. 3) . The deterioration of FAK activity was progressive with age being more affected in adult patients than in the 1 year old one. Thus both auto-and IL-8-mediated phosphorylation were strongly impaired in neutrophils of GSD 1b patients, while no changes were observed among neutrophils of healthy controls of different ages.
To define the changes in sub-cellular localization of cytoskeletal components that might accompany FAK and actin reductions, neutrophils were exposed to specific antibodies of selected target proteins and their binding sites revealed by fluorescent probes. In neutrophils from healthy volunteers, FAK was localized and concentrated at focal adhesion sites peripherally located, while in neutrophils of GSD Ib patients the stain intensity of these structures was dramatically reduced and the labeling more diffused (Fig. 4A) . A similar pattern of labeling was observed also with actin antibody, in neutrophils of controls and GSDlb patients (Fig. 4B ). FAK is a focal adhesion docking protein capable of facilitating the recruitment and activation of other tyrosinephosphorylated signaling molecules such as paxillin (28) . This protein, a substrate for FAK phosphorylation as shown using in vitro (29) and in vivo (30) systems, was accumulated at focal adhesion sites of control neutrophils, but the staining intensity GSD1b Control GSD1b that, following the uncapping, are available to form the cytoskeleton. Neutrophils from patients affected by GSO Ib showed a slight reduction in gelsolin levels (Fig. 5 ), a decrease that correlates with the changes in actin shown above (Fig . 2) . Treatment with G-CSF had partially reversed the was significantly decreased in GS O 1b neutrophils (Fig. 4C ) . Also vin cul in, one of the numerous structural proteins expressed at the cytoplasmic face of focal adhesions was affec ted (3 1). In cont rol neutrop hils, antibodies revealed the accumulation of vinculin in we ll defined spots at the cell per imeter, that resembled contact points , but we failed to detect any immunolabeling in GSO 1b neutrophils (Fig. 40) .
To co-localize paxillin and vinculin at focal adhesion sites labeled with FAK, we also performed doublestaining immunofluorescence but the weaker labeling compared to FAK and the FITC spilling did not allow double detection of the two proteins by means of a dual labeling even using the confocal microscopy.
Since gelsolin is an actin filament-capping protein and is involved in cell motility, we have monitored its expression. Gelsolin severing can have a constructive effect because it increases the number of filaments severe neutropenia of GSD1b patients. In our study we have monitored three GSDlb patients (age between 5 and 28) that were treated with G-CSF for three months. The number of leukocytes and neutrophils, although still below normal, was significantly higher than before treatment (Table II) , and the expressions of FAK and actin were close to control (Fig. 6 ). The autophosphorylation of FAK was also close to normal after G-CSF treatment (data not shown).
As shown above FAK function in GSDlb neutrophils was affected and likely in an agedependent manner. Although GSD Ib is a rear disorder, we could monitor a young patient from I to 3 and a half years of age. The disease was diagnosed at 6 months, and, as for the other patients, the proper corrections to food intake were soon implemented to improve metabolic conditions. At one year of age we collected the neutrophils. FAK expression was similar to control levels ( Fig. 7A and 7B) , while actin and gelsolin levels were slightly increased (Fig. 7C,  7D, 7E and 7F) . These data are different from those observed in neutrophils of the other GSD1b patients even for G, H, and I that were studied at 4 years of age ( Fig. I and 2 ). On the other hand even if the level ofFAK was normal, in neutrophils of the 1 year old patient the changes in gelsolin and actin suggested that, already at this age, some cytoskeletal rearrangements were taking place. This is reinforced by the data of Figure 3 , showing that auto-and IL-8 promoted phosphorylation of FAK were already affected at that age. These changes are probably the precursors of the alterations observed at later age.
The I year old patient was, then, treated with G-CSF for two and a half years, when we collected the blood sample. Treatment prevented the drop ofFAK expression while gelsolin and actin expression was still higher than control, as observed before the treatment with G-CSF at I year of age.
DISCUSSION
GSD Ib is a rare metabolic disorder of genetic origin characterized by a severe impairment of the carbohydrate metabolism. In our study we were able to enroll as many as II patients affected by GSD Ib. Most of them were affected by serious infections due to reduced number and functional impairment of neutrophils, a complication that is typical of GSD1b and apparently unrelated to the metabolic condition. The etiology of neutropenia and neutrophil dysfunction in GSD Ib is still unknown, and its relationship with the metabolic defect is still unclear. Differently from human GSD Ib disease, G6PT knockout (G6PT-/-) mice are transiently affected by neutropenia and defective neutrophil trafficking secondary to the impaired response to chemotactic factors and reduced production of specific chemokines at inflammation sites (9) . In addition, G6PT-/-mice show profound phenotypic changes such as reduced body growth that are not observed in metabolically compensated GSD Ib patients.
We investigated whether the reduced neutrophil function was related to changes in focal organizations of the cytoskeleton, i.e. expression, localization and function of FAK and related proteins. Neutrophil locomotion is mediated by the adhesion to substratum, that triggers the change in call shape typical of polymorphonuclear leukocytes during migration from blood stream into tissues. Integrins are one of the major links between extracellular matrix and bundles of microfilaments that form the stress fibers (32) . Their involvement in neutrophils dysfunction had recently been suggested since a patient affected by GSD Ib, with recurrent infections and typical impaired neutrophil function, presented a reduced expression of adherence receptors such as Lselectin CD62L and l» integrins CDII b/CDI8 (33). FAK plays an important role in integrin-mediated signal transduction pathway by regulating formation of focal complexes, cell motility and adhesiondependent cell survival. Integrin binding to extra cellular matrix promotes Rho-dependent FAK and paxillin phosphorylation (34) . In this study we have observed that neutrophils of patients affected by GSD Ib show reduced levels of FAK and actin, and the typical focal localization of FAK is significantly altered. In addition, FAK auto-and IL-8-promoted phosphorylation is greatly impaired. Normally IL-8 exposure promotes FAK phosphorylation and also affects its cellular redistribution. The reduction of FAK expression and activity, and its partial delocalization might underlie the impaired migrating capability of GSD Ib neutrophils. These FAK abnormalities are age dependent, since they worsen with time. For each single patient affected by GSD 1b it is reported the range oflower and higher values observed throughout the study for neutrophil and leukocyte number, lactic acid concentration and glycemia. "The normal paramethers for leukocytes are 4000 -11000/mm 3 • "The normal % ofneutrophils for patients of1 -6 years old is 30 -50%, for patients older than 6 years 50 -60%. 'The normal paramethers oflactic acid is in the range between 0.7-2.5 mMol/l. "The normal paramethersfor glycemia is in the range between 65 -110 mg/dl.
Patients with GSD 1b are often neutropenic and prone to recurrent infections; otherwise, the clinical features of GSD Ib could be indistinguishable from GSD lao FAK changes are peculiar of GSDlb neutrophil, suggesting that the impaired glucose metabolism, typical of both forms of the disease, may not be the cause of FAK deficiency. Since both GSD Ia and Ib patients received the same type of diet to correct the metabolic dysfunction and the changes in FAK were observed only in type 1b, the diet can also be ruled out as the cause of neutrophil alterations.
Paxillin is a signaling molecule that localizes to focal adhesion sites and is phosphorylated on tyrosine during integrin-mediated or growth factor-induced adhesion (34) . Paxillin interacts with FAK, and recruitment of FAK at focal contacts requires its binding to paxillin (35) . In neutrophils from GSD 1b patients, immunostaining of paxillin was weaker and defocalized as observed for FAK. Another affected component of the focal adhesion sites of neutrophils of GSD 1b patients is vinculin, which is reduced to an extent to be hardly immunodetected. This protein is part of the focal adhesion complex, and is associated with actin filament bundles that participate in the formation of the focal adhesion sites (34, 36) . In GSD 1b neutrophils, also actin is affected. The expression is reduced and its cellular localization is rather unfocalized and diffused. Thus the typical impairment of phagocytosis and chemotaxis of GSD 1b neutrophils may derive from the profound alterations of FAK submembrane apparatus combined with actin reduced expression.
Another function of actin filaments assembled at the plasma membrane is the generation of movement, that involves gelsolin-regulated remodeling (23) . Gelsolin null fibroblasts have pronounced actin stress fibers with defective chemotactic ability and reduced wound healing (37) . In our study, we observed that actin-severing gelsolin expression is higher than controls at 1 year of age, and then is lower. This reduction may contribute to the disorganization of submembrane cytoskeletal apparatus and to a higher vulnerability ofneutrophils. Such result was reported for cultured hippocampal neurons, where the lack of gelsolin was correlated with higher rate of cell death after exposure to glutamate (38) . On the other hand, the increased level of gelsolin at 1 year of age might be a compensatory initial reaction to actin impairment, that is aimed at counteracting cytoskeletal alterations and delaying functional impairment. Recombinant G-CSF therapy is clinically efficacious in reducing the incidence and severity of infections associated with GSD 1b (14) . It has been suggested that in some patients with GSD 1b, the neutropenia may not result from a failure to release mature granulocytes into the blood stream but from failure to mobilize marginating granulocyte pools (14) . In our study the percentage ofneutrophils was partially increased by the treatment with G-CSF, and the levels ofFAK and actin and FAK activity were restored as well. This finding suggests that the efficacy ofG-CSF therapy in infectionrelated symptoms of GSD 1b may be secondary to the improved function and number of the polymorphonuclear leukocytes. G-CSF treatment, however, fails to prevent the expression of markers of apoptosis in GSD 1b neutrophils (39) . Whether there is a correlation between the onset of apoptosis markers and the loss of FAK expression and function has to be defmed and is our next goal.
The modifications observed in neutrophils ofGSD1b patients appear to be age-dependent. In three patients of 4 years of age, FAK, actin and gelsolin levels were reduced, conversely in 1 year old patient FAK was at levels close to control, and the expression of actin and gelsolin was higher. These data suggest that the dynamic assembly and disassembly of actin cytoskeleton might also play an early role in neutrophil dysfunction. The plasticity ofthese early changes observed at 1 year ofage is also suggested by the normal expression ofFAK that, however, is markedly less active and, already, poorly activated by IL-8 stimulation. All such changes are prevented by treating patients with G-CSF.
In conclusion our data suggest that the recurrent infections in GSD 1b patients are likely due to the reduced number of neutrophils but also to the loss of function and organization of the focal adhesion complexes, that ultimately may affect function of GSD 1b neutrophils.
